https://www.hmpgloballearningnetwork.com/site/neuro/news/fda-approves-copper-histidinate-treatment-pediatric-menkes-disease
The US Food and Drug Administration (FDA) approved a copper histidinate (Zycubo) injection as the first treatment for Menkes disease in pediatric patients....
copper histidinatemenkes diseasefdatreatmentpediatric
https://www.pharmacytimes.com/view/copper-histidinate-becomes-first-only-fda-approved-treatment-for-menkes-disease
Subcutaneous copper histidinate injections deliver copper in a form that bypasses the genetic defect caused by Menkes disease.
copper histidinatefda approvedbecomesfirsttreatment